Ibrahim Abdallah Email & Phone Number

Cairo, Cairo Governorate, Eg

Egypt

* Engage with healthcare stakeholders to educate and communicate clinical and scientific data to advance the scientific platform as aligned with Amgen’s company goals and objectives*Educate and communicate clinical value, outcomes, and economic data to payers, providers, key stakeholders, advocacy, and access enablers*Respond to unsolicited inquiries consistent with the MSL compliance standards*Provide and/or present field observations and insights to internal stakeholders* Implement scientific engagement plan according to annual MSL goals and metrics* Develop and implement local OL plans in line with scientific engagement plan* Support speaker training as requested and ensure the speakers are updated on new data* Liaise with potential investigators in non-sponsored clinical research* Lead and/or participate on project teams that support MSL strategies and tactics as delegated by MSL leadership* Advance MSL value proposition, identify gaps, achieve results, and set an example for others to follow by consistently demonstrating Amgen values and leadership attributes. Demonstrate tact and integrity when communicating and interacting with others.* Lead and support congress activities as aligned with strategy* Compliantly collaborate with cross-functional colleagues. I may serve as main of point of contact* Maintain clinical acuity and expertise and timely completion of assigned training. I may serve as a training lead, New Hire Mentor and/or International MSL mentor/trainer

Cairo, Egypt

* Responsible for BMS Immuno-Oncology portfolio (OPDIVO® & YERVOY®) in more than 10 indications. * Contribute to development and delivery of scientifically meaningful medical programs/projects in line with the local Medical and Field Medical plan.* As necessary and appropriate, support the initial and ongoing medical/scientific area and product specific training and provide key scientific updates to internal stakeholders (e.g. Commercial, Regulatory, Pharmacovigilance, Legal, HEOR, Value Access & Payment).* As necessary and appropriate, support the initial and ongoing medical/scientific area and product specific training and provide key scientific updates to internal stakeholders (e.g. Commercial, Regulatory, Pharmacovigilance, Legal, HEOR, Value Access & Payment).* Demonstrate proficiency in using available scientific resources and presentations. Effectively present information to TL/HCPs and be able to respond to questions, ensuring medical accuracy and compliance with local procedures, ethical and legal guidelines and directives.* Actively assess the medical landscape by meeting with TL/HCPs to understand their needs and expertise.* Collect and provide meaningful medical insights and/or impact by communicating these back to the medical and commercial organizations to be actioned in support of the strategy development.

Cairo, Egypt

* Orchestrate channels and cross-functional resources, engage both F2F and digitally, provide solutions beyond the product & use analytics to tailor engagement.* Promotes Novartis portfolio and services by providing the latest, relevant and authorized data, key messages and disease information to the right customer at the right time.* Supports HCP decision making and optimize patient outcomes in an ethical way.* Supports the achievement of Novartis business goals by implementing value-based solutions with customers and designated accounts.* Carrying customer facing activities primarily focusing on care management tackling pain-points of the full patient cycle (Awareness, Diagnosis, treatment, Follow up).

Cairo, Egypt

- Franchise: Oncology (Solid Tumors)- Line: Breast Cancer- Products: Piqray® + Afinitor®- Area: Cairo University Hospital (Kasr Al Ainy) + Private Hospitals and Clinics in Giza Governorate ( Mohandesin, Dokki, Agouza, 6 October) - Responsibilities and Achievements: * Launching Piqray, the first biomarker-driven treatment for Advanced Breast Cancer in 40 years.* Preparing the oncology market before launching through increasing awareness about molecular testing in ABC patients.* Maximizing Afinitor® Market share within the Breast Cancer market in private and public sectors.

Cairo Governorate, Egypt

- Franchise: Oncology (Solid Tumors)- Line: Breast Cancer- Products: Kisqali® + Afinitor®- Area: Cairo University Hospital (Kasr Al Ainy) + Private Hospitals and Clinics in Giza Governorate ( Mohandesin, Dokki, Agouza, 6 October) - Responsibilities and Achievements: * Completing on the successful Kisqali® Launch in Egypt and being part of the team who contributed to serving the majority of Breast Cancer patients with this new and novel drug.* Leading the market with 50%+ Market share Vs. other drugs of the same class. * Going beyond the private business and being able to access such a novel treatment into public university hospitals through collaboration with the hospital Key Decision Makers to serve Breast Cancer patients there who might not be able to afford the drug.* Being able to access Kisqali® into my assigned Public Health Insurance Hospitals.* Maximizing Afinitor® Market share within the Breast Cancer market in private and public sectors.

Cairo + Upper Egypt.

- Franchise: Oncology (Solid Tumors)- Line: Rare Tumors (Kidney Cancer RCC, Neuro-endocrine Tumors NETs & Soft Tissue Sarcoma STS)- Products: Votrient® & Sandostatin LAR® - Area: National Cancer Institute, Ain Shams University Hospital, Nasser Institute (Main Accounts) + Private Oncology clinics in Manial, Maadi, Downtown, Nasr City & Heliopolis. In addition to University Hospitals, Oncology Institutions and Public Health Insurance Hospitals in Baniswef, El-Minya, Assuit, Sohag, Luxor & Aswan. - Responsibilities & Achievements:* Launching Sandostatin LAR® across the country for the treatment of NeuroEndocrine Tumors and Acromegaly. * Increasing awareness for these rare tumors and trying to deliver the maximum benefit for patients.* Access all patients eligible for our brands by being patient centric. * Arranging group meetings for health-care professionals to ensure that the latest developments in the field are reaching them.

Cairo + Upper Egypt

Same Line, Products, Area and Responsibilities as the previous position.

Cairo + Upper Egypt

- Franchise: Oncology (Solid Tumors)- Line: Breast Cancer - Products: Afinitor®, Tykerb® & Votrient® ( Votrient® for kidney cancer, promoting in remote areas only)- Area: Ain Shams University Hospital (Main Account) + Private Oncology Clinics in Manial, Maadi & Downtown. In addition to University Hospitals, Oncology Institutions and Public Health Insurance Hospitals in Baniswef, El-Minya, Assuit, Sohag, Luxor & Aswan. - Responsibilities & Achievements: * Re-Launching Tykerb® for HER2+ve breast cancer and Votrient® for Kidney Cancer, after the global acquisition of GSK oncology portfolio by Novartis Oncology. * Serving HER2+ve breast cancer patients in public health insurance hospitals in Cairo and remote areas.* Being able to access public MOH hospitals and serve kidney cancer patients after Votrient® got the state-funded treatment code. * Taking the lead in enlisting Votrient® in Baniswef University Hospital tender. * Taking the lead in enlisting the Solid Tumors Portfolio in AOI Hospital tender.

Cairo + Fayoum + Baniswef

- Franchise: Oncology (Solid Tumors)- Line: Breast Cancer- Products : Afinitor, Femara & Zometa - Area: Ain Shams University Hospital (Main Account) + Private Oncology Clinics in Manial, Maadi & Downtown. In addition to University Hospitals and Public Health Insurance Hospitals in Fayoum & Baniswef as remote areas.- Responsibilities & Achievements:* Serving accounts with different management styles (Universities, MOH, HI, Private).* Establishing rapport with all HCPs and KOLs in the accounts. * Being able to nearly double the number of patients who benefit from Novartis' cancer drugs in the accounts.* Fully Supporting any scientific activity in the accounts.

Cairo, Egypt

•Dispense prescription medicines to the public. •Ensure that different medications are compatible. •Check dosage and ensure that medications are correctly and safely supplied and labeled.

Cairo, Egypt

• Helping the teaching assistant (TA) in preparation of lab experiments.• Attending the Pre-lab meeting.• Helping students during the lab session.

Cairo, Egypt

GUC Alzheimer's Disease Research Unit's (GADU) vision is to create healthy scientific atmosphere that enrich the research ability of the department and to achieve different goals. The unit's goals is to enhance undergraduate students to understand and experience the research environment together with postgraduate candidates who are enrolled in their masters work. Moreover to encourage the postgraduates candidates to practice how they perform fruitful scientific discussion with other colleagues and how to defend the results of their work and exchange information on continuous basis.

Cairo, Egypt

•Inspect products being manufactured on different parts of the production line. •Ensure that the product complies with the SOPs and GMP protocols. •Inspect machines’ operation and cleaning

Cairo, Egypt

•Communicate with community pharmacists about appropriate patient counseling. •Advise community pharmacists about specific company products and the right way of taking the dose. •A target of 100 pharmacies in the assigned area was achieved

Cairo, Egypt

GUC-SPSA (German University in Cairo's Scientific Pharmaceutical Students' Association) is a student association that studies and promotes the interests of pharmacy students and enhances cooperation among fellow GUCians as well as other young pharmacists in Egypt and worldwide.

Bachelor Of Pharmacy (Bpharm), Pharmaceutical Sciences And Biotechnology, Excellent With Honors

Activities and Societies: GUC-SPSA, GADU research group

Master Of Business Administration - Mba, International Marketing

Career Certificate In Sales & Marketing, Marketing